Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Guangzheng Eye Hospital Group Co.,Ltd. (002524.SZ)

4.0000
+0.0300
+(0.76%)
At close: 3:04:54 PM GMT+8
Loading Chart for 002524.SZ
  • Previous Close 3.9700
  • Open 3.9200
  • Bid 3.9900 x --
  • Ask 4.0000 x --
  • Day's Range 3.9700 - 4.1000
  • 52 Week Range 2.9000 - 5.0400
  • Volume 12,184,000
  • Avg. Volume 20,417,672
  • Market Cap (intraday) 2.074B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 28, 2013
  • 1y Target Est --

Guangzheng Eye Hospital Group Co., Ltd. provides various ophthalmic medical services in China. It operates through Steel Structure, Energy, and Medical and Health Sector segments. The company offers diagnosis and treatment of various eye diseases; medical optometry services; invests in, operates, and manages eye hospitals; and provides related services. In addition, it researches ophthalmic medical technology; sells and transports natural gas; and builds steel structure. Further, the company engages in leasing of houses; and property and consulting services. Guangzheng Eye Hospital Group Co., Ltd. was founded in 2001 and is headquartered in Xinjiang, China.

www.gzykcn.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 002524.SZ

View More

Performance Overview: 002524.SZ

Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002524.SZ
9.89%
SSE Composite Index (000001.SS)
1.06%

1-Year Return

002524.SZ
7.41%
SSE Composite Index (000001.SS)
5.58%

3-Year Return

002524.SZ
35.90%
SSE Composite Index (000001.SS)
10.48%

5-Year Return

002524.SZ
46.88%
SSE Composite Index (000001.SS)
15.22%

Compare To: 002524.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002524.SZ

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    2.06B

  • Enterprise Value

    2.83B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.28

  • Price/Book (mrq)

    18.04

  • Enterprise Value/Revenue

    3.14

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -17.23%

  • Return on Assets (ttm)

    0.90%

  • Return on Equity (ttm)

    -79.50%

  • Revenue (ttm)

    901.47M

  • Net Income Avi to Common (ttm)

    -155.35M

  • Diluted EPS (ttm)

    -0.3000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    80.99M

  • Total Debt/Equity (mrq)

    629.45%

  • Levered Free Cash Flow (ttm)

    137.12M

Research Analysis: 002524.SZ

View More

Company Insights: 002524.SZ

Research Reports: 002524.SZ

View More

People Also Watch